Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsTransplantation ConditioningTransplantation, HomologousHematopoietic Stem Cell MobilizationMelphalanCyclophosphamideMultiple MyelomaTreatment OutcomeHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Lymphoma, Non-HodgkinMyeloablative AgonistsBlood Component RemovalGraft vs Host DiseaseEtoposideRemission InductionSalvage TherapyBusulfanBone Marrow TransplantationThiotepaRecurrenceGraft SurvivalHematopoietic Stem CellsCarmustineStem CellsDisease-Free SurvivalAntineoplastic Agents, AlkylatingHodgkin DiseaseCytarabineVincristineAmyloidosisIfosfamideSurvival RateAntineoplastic AgentsSurvival AnalysisRetrospective StudiesDoxorubicinWhole-Body IrradiationCord Blood Stem Cell TransplantationTransplantation ChimeraCytophagocytosisHematopoiesisBone Marrow PurgingTissue DonorsTime FactorsDexamethasoneNeoplasmsFollow-Up StudiesPrednisoneCarboplatinLeukemia, Myeloid, AcuteLymphomaPrognosisHistocompatibilityHistocompatibility TestingImmunosuppressive AgentsInfectionLiver TransplantationProspective StudiesPlatelet CountVidarabineLymphoma, T-CellLeukemiaTransplantation, IsogeneicFeasibility StudiesFatal OutcomeMyelodysplastic SyndromesPOEMS SyndromeMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectRecombinant ProteinsChemotherapy, AdjuvantBlood Cell CountNeoplasm, ResidualCytomegalovirus InfectionsAntibodies, Monoclonal, Murine-DerivedLymphoma, Mantle-CellBreast NeoplasmsCell TransplantationBlood CellsBone MarrowBlood Transfusion, AutologousPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationT-LymphocytesEmbryonic Stem CellsHematologic DiseasesPodophyllotoxinImmunophenotypingBoronic AcidsAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositivePyrazines